Peter Greenleaf | President & Chief Executive Officer |
Joe Miller | Chief Financial Officer |
Ed Arce | H.C. Wainwright |
Joseph Schwartz | SVB Securities |
Ken Cacciatore | Cowen & Company |
Justin Kim | Oppenheimer & Company |
Sahil Dhingra | RBC Capital Markets |
David Martin | Bloom Burton |
Maury Raycroft | Jefferies |
Greetings, and welcome to Aurinia Pharmaceuticals Inc.
Third Quarter 2022 Earnings Call. At this time all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.